Literature DB >> 1853346

The acute hepatotoxicity of the isomers of dichlorobenzene in Fischer-344 and Sprague-Dawley rats: isomer-specific and strain-specific differential toxicity.

E R Stine1, L Gunawardhana, I G Sipes.   

Abstract

The acute hepatotoxicity of the three isomers of dichlorobenzene (DCB) was evaluated in male Fischer-344 (F344) rats at various times following ip administration. Plasma alanine aminotransferase (ALT) activity, measured in F344 rats 24 hr postexposure, was dramatically elevated following doses of 1.8-5.4 mmol/kg of o-DCB. Conversely, equimolar doses of p-DCB produced no such toxicity, while m-DCB produced intermediate hepatic injury at or above doses of 2.7 mmol/kg. Histopathological changes in livers from treated animals qualitatively reflected elevations in 24-hr plasma ALT activity (time to maximal elevation). Phenobarbital pretreatment potentiated the acute hepatotoxicity of o- and m-DCB, but did not affect the toxicity of p-DCB. Likewise, SKF-525A pretreatment inhibited the hepatotoxicity of o-DCB. Equimolar doses of o- and m-DCB produced approximately equivalent depletion of intrahepatic glutathione, while p-DCB had no effect on hepatic GSH. Furthermore, prior depletion of hepatic glutathione by pretreatment with phorone markedly potentiated the hepatotoxicity of o- and m-DCB, while increasing the toxicity of p-DCB to a far lesser degree. The differential hepatotoxicity of the o- and m-DCB does not appear to be explained adequately by differences in their hepatic distribution or in vivo covalent binding to hepatic proteins. Interestingly, male Sprague-Dawley (SD) rats are relatively refractive to the acute hepatotoxicity of o-DCB following ip administration of 1.8 and 5.4 mmol/kg. The combination of these dramatic differences (structure-activity and animal strains) should be useful in elucidating key events involved in the hepatotoxicity caused by these compounds.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853346     DOI: 10.1016/0041-008x(91)90010-c

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Heat map visualization of high-density clinical chemistry data.

Authors:  J Todd Auman; Gary A Boorman; Ralph E Wilson; Gregory S Travlos; Richard S Paules
Journal:  Physiol Genomics       Date:  2007-07-24       Impact factor: 3.107

2.  In vitro transcriptomic prediction of hepatotoxicity for early drug discovery.

Authors:  Feng Cheng; Dan Theodorescu; Ira G Schulman; Jae K Lee
Journal:  J Theor Biol       Date:  2011-08-27       Impact factor: 2.691

3.  Effect of structural modifications on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

Authors:  Niti N Patel; Christine M Crincoli; Douglas M Frederick; Ruy Tchao; Peter J Harvison
Journal:  J Appl Toxicol       Date:  2011-02-21       Impact factor: 3.446

4.  Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.

Authors:  N N Patel; C M Crincoli; E L Kennedy; D M Frederick; R Tchao; P J Harvison
Journal:  Xenobiotica       Date:  2008-04       Impact factor: 1.908

5.  Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

Authors:  Christine M Crincoli; Niti N Patel; Ruy Tchao; Peter J Harvison
Journal:  Toxicology       Date:  2008-06-25       Impact factor: 4.221

6.  Doxycycline suppression of ischemia-reperfusion-induced hepatic injury.

Authors:  J R Smith; W L Gabler
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

Review 7.  Role of tissue repair in toxicologic interactions among hepatotoxic organics.

Authors:  M G Soni; H M Mehendale
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.